Multi-omics integrated with machine learning identifies LPS-related genes potentially associated with iron metabolism-Immune axis imbalance in PCOS: a bioinformatics-based exploration of mechanisms and diagnostic markers
A potentially previously unrecognized association among lipopolysaccharide-related genes, iron metabolism imbalance, and immune dysregulation in polycystic ovary syndrome is suggested, thereby providing a potential framework for future mechanistic investigations and the development of diagnostic and therapeutic targets.
Abstract
Chronic low-grade inflammation induced by bacterial lipopolysaccharide has been implicated in the pathogenesis of polycystic ovary syndrome; however, the genetic mechanisms linking lipopolysaccharide signaling to immune and metabolic dysregulation remain insufficiently elucidated. In the present study, transcriptomic datasets and single-cell sequencing data related to polycystic ovary syndrome were analyzed in combination with lipopolysaccharide-related genes retrieved from a toxicogenomics database. Differential expression analysis, weighted gene co-expression network analysis, clustering analysis, and machine learning algorithms were integrated to identify candidate biomarkers. Subsequently, functional enrichment analysis, immune cell infiltration analysis, regulatory network construction, and drug prediction analyses were conducted, while single-cell sequencing analysis was employed to identify key cellular populations and characterize gene expression dynamics. Two genes, C11orf68 and EVI5L, were identified as potential biomarkers and were significantly downregulated in patients with polycystic ovary syndrome. Functional analyses associated these genes with iron metabolism and immune regulation, whereas immune infiltration profiling identified T lymphocytes as key effector cells involved in disease progression. These findings suggest a potentially previously unrecognized association among lipopolysaccharide-related genes, iron metabolism imbalance, and immune dysregulation in polycystic ovary syndrome, thereby providing a potential framework for future mechanistic investigations and the development of diagnostic and therapeutic targets.
This study defines an RAS-SLC11A2 molecular framework linking iron metabolism dysregulation to PCOS-related cardiometabolic risk, elucidating the mechanisms connecting ovarian dysfunction, inflammation, oxidative stress and hypertension, and supports gentiopicroside as a promising therapeutic candidate.
Si-Han Zhang, Yu Xu, Tingting Cao et al.· Clinical and experimental hy...· 0 citations
This study identified sphingolipid-related molecular signatures with potential diagnostic and prognostic value in IPF and highlighted CCDC80 as a candidate profibrotic regulator and further validation in larger and clinically standardized cohorts is required before clinical translation.
Yi Liao, Lingjing Yang, Xiaoshu Liu et al.· Orphanet Journal of Rare Dis...· 1 citation
GADD45A is a promising biomarker for the diagnosis and prognosis of sepsis and may promote disease progression by enhancing R-loop accumulation and DNA damage.
Min Chen, Jie-Xiang Kang, Shi-Ying He et al.· Shock· 0 citations
An integrative transcriptomic and immune-genomic characterization of chronic insomnia is provided and SPTLC1, PTGES3, and HLA-G are identified as candidate hub genes associated with oxidative-stress-related immune signatures.
Zhi-Peng Xin· Egyptian Journal of Medical...· 0 citations
The findings suggest that CCL4 may serve as a potential diagnostic biomarker for AMI, and the observed immune-metabolic associations provide a basis for future mechanistic and translational studies.
Jin-Zhong Bo, Y. Xiang, Yanshuo Ni et al.· Journal of Visualized Experi...· 0 citations
Findings suggest that metabolic alterations in AN directly influence immune regulation, and a novel metabolic-immune pathway with therapeutic potential in AN is revealed.
Yan-Bo Sun, Cong-Hui Xu, Jing Luo et al.· European Archives of Psychia...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.